However, this template is not a substitute for the Federal Food, Drug, and Cosmetic Act (FD&C Act) or the Code of Federal Regulations (CFR) and does not necessarily contain all information required to ensure compliance in a given situation.
Disclaimer: The purpose of this informed consent template is to assist investigators with preparing an informed consent document for the treatment of a single patient with an investigational drug under the expanded access program.
